Welcome to clonexpress.com









.
Technology:
Patient-Specific cells: Beta Cells, Dopaminergic neuron, Hepatocytes
Clonexpress has developed a patented technology to develop patient-specific
differentiated cell types from human primary fibroblasts and peripheral blood
mononuclear cells (PBMNC) by epigenetic induction.

Cost effective development of patient-specific pancreatic beta cells, hepatocytes,
neuronal cells from PBMNC provided by investigators. Fast turnaround time (usually
about 4-6 weeks).
Send enquiries.
Technology

Cell Lines available for evaluation and licencing:

Human fetal and adult pancreatic beta cell   
Human dopaminergic neuron
Human neuronal progenitor cell
Human astrocytes

Additional cell lines are under different stages of development.
Clonexpress also provides human CNS primary cells and other primary cell
types for
in vitro research.
Astrocytes   HAST     
Dopaminergic neuron cells   DAN Cells  
Microglial cells   HMG
Neuronal progenitor cells   HNPC
Hepatocytes - Special Introductory offer
Pancreatic beta cells - Special Introductory offer


 
CLONEXPRESS
                                           Innovations in Cell Based Therapy and Drug Discovery